Clinical Trials Logo

Body Weight clinical trials

View clinical trials related to Body Weight.

Filter by:

NCT ID: NCT03201081 Completed - Body Weight Clinical Trials

Motivational Resistance-training Program on Adherence and Body Composition in Elderly

Start date: January 15, 2017
Phase: N/A
Study type: Interventional

Lack of physical activity is one of the major causes for obesity and functional disability in the elderly. Including regular exercise in elderly´s lifestyle is not an easy task. The main objective was to analyse the effect of a motivational resistance-training programme on satisfying the individual´s psychological needs, level of self-determination and body composition. A quasi-experimental study was performed with 47 volunteers (29 females, 18 males) of 67-75 years of age, divided into two groups: experimental (n = 27) and control (n = 20). A 12-week intervention programme was performed, with a total of 36 sessions.

NCT ID: NCT03191331 Completed - Clinical trials for Overweight and Obesity

Dietary Intervention, Gestational Weight Gain and Gestational Diabetes.

Start date: June 6, 2017
Phase: N/A
Study type: Interventional

The aim of this pilot study is to conduct a dietary intervention for overweight (body maas index BMI≥25) and obese (BMI≥30) pregnant women in two maternity care clinics and explore the effect of the intervention on gestational weight gain and the prevalence of gestational diabetes between the intervention and control groups.

NCT ID: NCT03188094 Active, not recruiting - Weight Loss Clinical Trials

Integrated Community-Clinical Linkage Model to Promote Weight Loss Among South Asians With Pre-Diabetes

Start date: December 17, 2018
Phase:
Study type: Observational

The proposed study will inform efforts to prevent diabetes and promote weight loss in a high-risk population and generate a reproducible, scalable, and sustainable model for use with other insurer groups and clinical settings that work in immigrant populations with a high burden of chronic disease.

NCT ID: NCT03187938 Completed - Clinical trials for Low Birth Weight Infants

Alkaline Phosphatase Level in Pregnancy and Its Association With Birth Weight

Start date: June 14, 2017
Phase:
Study type: Observational

Alkaline phosphatase is known to be produced by syncytiotrophoblasts in the placenta and its levels are normally increased in pregnancy. Therefore, it would be reasonable to hypothesize that alkaline phosphatase would be low to low normal in cases of low birth weight / intrauterine growth restriction (IUGR)/ placental insufficiency.

NCT ID: NCT03187769 Completed - Schizophrenia Clinical Trials

Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder

Start date: June 8, 2017
Phase: Phase 3
Study type: Interventional

This study will evaluate the effect of ALKS 3831 compared to olanzapine on body weight in young adults with schizophrenia, schizophreniform, or bipolar I disorder who are early in their illness

NCT ID: NCT03186820 Completed - Endometriosis Clinical Trials

Exploratory Study of the Interest of MRI Susceptibility Weighted Imaging for the Pre-operative Assessment of Pelvic Endometriosis Extent

EndoSWI
Start date: June 19, 2017
Phase: N/A
Study type: Interventional

Knowledge of the precise location of endometriosis is essential for a successful surgical treatment. MRI Susceptibility-Weighted Imaging (SWI-MRI) yields high sensitivity for blood by-products detection. Since endometriosis lesions are haemorrhagic, and therefore rich in blood by-products such as hemosiderin, SWI-MRI could be useful in the pre-operative assessment of endometriosis, especially in superficial peritoneal lesion detection. The purpose of our study is to evaluate the performance of SWI-MRI for the preoperative work-up of endometriosis

NCT ID: NCT03180489 Completed - Weight Loss Clinical Trials

Does Dapagliflozin Provide Additional Health Benefits To Dietary Counseling For Weight Loss?

Start date: May 3, 2017
Phase: Phase 2
Study type: Interventional

Dapagliflozin is a medicine to treat diabetes. Its mechanism of action is via sodium-glucose co-transporter 2 (SGLT2) inhibition. In adults with diabetes, use of sodium-glucose co-transporter 2 inhibitors is associated with moderate weight (fat) loss, in addition to other health benefits, including decreased blood pressure, decreased inflammation, and decreased oxidative stress. It is unclear as to whether these health benefits are due to SGLT2 inhibition per se, or as a secondary effect of weight loss. We wish to compare the health benefits of dietary counseling for weight loss with and without concomitant use of an SGLT2 inhibitor.

NCT ID: NCT03171207 Not yet recruiting - Stroke Clinical Trials

Evaluation of a Novel Gait Training Device to Support Body Weight

Start date: June 2017
Phase: N/A
Study type: Interventional

A novel body weight support device that uses pressurized pants may provide advantages in delivering gait therapy. The objectives of this study are to test the following hypotheses that 1) the novel device will allow for increased body weight support while improving or maintaining the same level of patient comfort; 2) the novel device will yield greater patient satisfaction with gait therapy relative to current harness systems; 3) therapists will be more satisfied with the use of the novel device relative to current harness systems; 4) the use of the novel device will require less total therapist time than a harness comparator; 5) the use of the novel device will increase therapeutic treatment time when compared with current harness systems.

NCT ID: NCT03163212 Not yet recruiting - Safety Issues Clinical Trials

Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants

Start date: June 2017
Phase: Early Phase 1
Study type: Interventional

This study will examine the safety and tolerability of supplementation with bovine lactoferrin with fructo-oligosaccharide a simple sugar in very low birth weight infants. Lactoferrin is a major whey protein in mother's milk and plays a role in promoting a mature and healthy gut. It also has antimicrobial and immunomodulation activities.

NCT ID: NCT03159689 Completed - Overweight Clinical Trials

The Effect of a Healthy Snack on Body Weight and Composition

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

The results from this study may help to explain if incorporating mixed nuts in a reduced calorie diet will lead to weight loss.